Monthly Archives: October 2018

Ambulatory Surgery Center Market Report 2018 Focuses on Production, Consumption, Revenue (Million USD), Market Share and Growth Rate: Radiant Insights, Inc.

SAN FRANCISCO, October 24, 2018 /PRNewswire/ -- The global ambulatory surgery center market is subject to witness a substantial growth over the forecast period due to the growing geriatric population, rising occurrence of chronic diseases, surging in healthcare costs, and recent technological advancements in the healthcare sector. However, absence of expertise and increase in number of reimbursement issues are

By |2018-10-24T16:38:35+00:00October 24th, 2018|Financial|

Stryker completes acquisition of Invuity, Inc.

Kalamazoo, Michigan - October 23, 2018 - Stryker (NYSE:SYK) announced today the completion of its previously announced acquisition of Invuity, Inc.  Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide variety of clinical applications including orthopaedic and spine surgery, general surgery and women's health procedures, and is a recent

By |2018-10-23T22:23:29+00:00October 23rd, 2018|Financial|

Clinical Study Shows DJO’s “Dual-Pivot” Knee Replacement Technology Reduces Patient Dissatisfaction, Improves Function and Activity Levels

October 23, 2018 AUSTIN, Texas--(BUSINESS WIRE)--DJO (“DJO” or the “Company”), a leading provider of medical technologies designed to get and keep people moving, released a new clinical study to show that EMPOWR 3D Knee technology reduces patient dissatisfaction, and improves function and activity levels. Based on a multitude of studies on the biomechanics and kinematics

By |2018-10-23T17:08:51+00:00October 23rd, 2018|Recon, Top Stories|

Regentis Biomaterials Expands SAGE Clinical Trial of GelrinC™ for Knee Pain

October 23, 2018 PRINCETON, N.J. & OR AKIVA, Israel--(BUSINESS WIRE)--Regentis Biomaterials today announced it has expanded the SAGE clinical trial of GelrinC™ for the treatment of articular cartilage damage in the knee to 11 U.S. sites. GelrinC is an investigational device being evaluated as a treatment to help the body regrow cartilage in the knee. Articular cartilage

By |2018-10-23T15:42:27+00:00October 23rd, 2018|Biologics|

Global Collagen Meniscus Implant Market to Surpass US$ 565.6 Million by 2026 – Coherent Market Insights

Seattle, Oct. 22, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global collagen meniscus implant market was valued at US$ 358.8 million in 2017 and is projected to exhibit a CAGR of 5.4% over the forecast period (2018–2026). To know the latest trends and insights prevalent in this market, click the link below:

By |2018-10-22T20:52:51+00:00October 22nd, 2018|Financial|

BONESUPPORT starts selling CERAMENT® BONE VOID FILLER Direct in the US via its own New Distributor Network

Lund, Sweden, 08:00 CET, 22 October 2018 -BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, announces that it has started selling CERAMENT® BVF direct via its own US distributor network. Emil Billbäck, BONESUPPORT’s CEO said “The launch of our own US distribution network is a key strategic milestone as we work towards

By |2018-10-22T20:22:14+00:00October 22nd, 2018|Biologics, Top Stories|

Shoulder Innovations Announces Close Of $2.5 Million Round In Series A Investment

HOLLAND, Mich., Oct. 22, 2018 /PRNewswire/ -- Shoulder Innovations, an emerging leader in the development of shoulder replacement systems, announced today it has closed a $2.5 million round of Series A equity funding led by Ann Arbor-based Michigan Angel Fund, Grand Rapids-based Wakestream Ventures, Genesis Innovation Group, cultivate(MD) and other equity holders. "It is impressive that the team at Shoulder Innovations has developed truly cutting-edge

By |2018-10-22T16:18:18+00:00October 22nd, 2018|Financial|

Intuitive Surgical Announces Third Quarter Earnings

SUNNYVALE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), a global technology leader in robotic-assisted, minimally invasive surgery, today announced financial results for the quarter ended September 30, 2018. Q3 Highlights Worldwide da Vinci procedures grew approximately 20% compared with the third quarter of 2017, driven primarily by growth in U.S.

By |2018-10-19T21:28:43+00:00October 19th, 2018|Financial|

OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Small Stature Scoliosis System with 26th Surgical System

WARSAW, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new RESPONSE 4.5/5.0mm System for treating smaller stature younger patients with complex scoliosis.  The system represents the

By |2018-10-19T15:53:09+00:00October 19th, 2018|Regulatory, Spine, Top Stories|

NuVasive Names J. Christopher Barry To Succeed Gregory T. Lucier As Chief Executive Officer; Lucier To Remain Chairman Of The Board

SAN DIEGO, Oct. 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its Board of Directors has named J. Christopher Barry to succeed Gregory T. Lucier as chief executive officer (CEO) effective November 5, 2018. Mr. Barry will join the NuVasive Board of Directors; Mr. Lucier

By |2018-10-19T15:38:32+00:00October 19th, 2018|Spine|